Int. J. Radiat. Oncol. Biol. Phys. 2016-07-15
Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
ABSTRACT
PURPOSE
To investigate the local control and radiation-induced brain necrosis in patients with brain metastases >2 cm in size who received single-fraction or multifraction stereotactic radiosurgery (SRS); factors associated with clinical outcomes and the development of brain radionecrosis were assessed.
METHODS AND MATERIALS
Two hundred eighty-nine consecutive patients with brain metastases >2.0 cm who received SRS as primary treatment at Sant'Andrea Hospital, University of Rome Sapienza, Rome, Italy, were analyzed. Cumulative incidence analysis was used to compare local control and radiation-induced brain necrosis between groups from the time of SRS. To achieve a balanced distribution of baseline covariates between treatment groups, a propensity score analysis was used.
RESULTS
The 1-year cumulative local control rates were 77% in the single-fraction SRS (SF-SRS) group and 91% in the multifraction SRS (MF-SRS) group (P=.01). Recurrences occurred in 25 and 11 patients who received SF-SRS or MF-SRS (P=.03), respectively. Thirty-one patients (20%) undergoing SF-SRS and 11 (8%) subjected to MF-SRS experienced brain radionecrosis (P=.004); the 1-year cumulative incidence rate of radionecrosis was 18% and 9% (P=.01), respectively. Significant differences between the 2 groups in terms of local control and risk of radionecrosis were maintained after propensity score adjustment.
CONCLUSIONS
Multifraction SRS at a dose of 27 Gy in 3 daily fractions seems to be an effective treatment modality for large brain metastases, associated with better local control and a reduced risk of radiation-induced radionecrosis as compared with SF-SRS.
Related Questions
New answer by Radiation Oncologist at Oakland University William Beaumont School of Medicine (September 15, 2017)
There is not a set answerIt matters on the pathology being treated. size and location of the tumor as well as the equipment being utilized. Frame can help reduce margin, incre...
How should they be prioritized? V10, V12, mean brain dose, prior WB radiation? To what extent should tumor coverage, conformality and homogeneity be c...
New comment by Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center ( June 21, 2019)
For a more in-depth explanation of the 5 fraction stereotactic technique, and the 28.8 Gy in 5 fraction origin, please look at the following two publications:
Fractionated ...
Are there treatment planning considerations that are different for a large cystic lesion as compared to a solid metastasis?
New answer by Radiation Oncologist at Oakland University William Beaumont School of Medicine (October 15, 2017)
The differing views of the cystic metastasis have been discussed. UCSF published on worse control with cystic lesions and I swear this is brought up at almost every stereotact...
What factors influence your choice of SRS vs more fractionated regimens?
New comment by Radiation Oncologist at Mercy Health Johnson Family Cancer Center ( April 14, 2023)
Is there a size where you would consider a more fractionated regimen?
Do you treat on consecutive days or more protracted interfraction intervals? Does tumor type (benign vs malignant) or size influence your choice?
New comment by Radiation Oncologist at Vanderbilt-Ingram Cancer Center ( July 5, 2022)
I generally do 27/3 every other day. If I was doing 30Gy in 5, I would do daily.
How does the presence of prior WBRT alter your treatment plan?
New comment by Radiation Oncologist at Beaumont Hospital ( February 12, 2021)
Our experience may be a bit different. We have treated about 20 patients with F SRS following resection and in about 1/2 of the cases, there has been post op MRI evidence of r...